References
  1. Cui, S, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Hemostasis. 2020; 00: 1-4.
  2. Klok, FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. 2020. DOI: 10.1016/j.thromres.2020.04.013.
  3. Oxley, T, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. New England Journal of Medicine. 2020. DOI: 10.1056/NEJMc2009787.
  4. Zhang, L, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of Thrombosis and Hemostasis. 2020. DOI:10.1111/JTH.14859.
  5. Tang, N, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy . Journal of Thrombosis and Hemostasis. 2020; 18: 1904-1099.
  6. Spieza, L et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for acute Respiratory Failure. Thrombosis and Haemostasis. 2020 DOI: 10.1055/s-0040-1710018.
  7. Rannucci M et al. The procoagulant pattern of patients with COVID 19 acute respiratory distress syndrome. Journal of Thrombosis and Hemostasis. 2020. DOI:10.1111/JTH.14854.
  8. Connors JM, and Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020, 135(23): 2033-2040.
  9. Spyropoulos et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. Journal of Thrombosis and Haemostasis. 2020. DOI: 10.1111/jth.14929
  10. Loi M et al. COVID-19 anticoagulation recommendations in children. Pediatric Blood and Cancer. 2020. DOI: 10.1002/pbc.28485.
  11. Oswald, E et al. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. British Journal of Anaesthesia. 2010:6:827-835.